D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
Snowflake
SNOW
|
+$429M |
| 3 |
Citigroup
C
|
+$383M |
| 4 |
Oracle
ORCL
|
+$365M |
| 5 |
Sea Limited
SE
|
+$360M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$597M |
| 2 |
Apple
AAPL
|
+$579M |
| 3 |
Mastercard
MA
|
+$525M |
| 4 |
Walt Disney
DIS
|
+$428M |
| 5 |
Booking.com
BKNG
|
+$416M |
Sector Composition
| 1 | Technology | 19.98% |
| 2 | Consumer Discretionary | 13.5% |
| 3 | Financials | 10.53% |
| 4 | Healthcare | 10.18% |
| 5 | Communication Services | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RUBY
2651
DELISTED
Rubius Therapeutics, Inc
RUBY
| $890K | ﹤0.01% |
91,916
-11,278
| -11% | -$109K |
|
2652
National Vision
EYE
$1.82B
| $887K | ﹤0.01% |
18,486
-37,382
| -67% | -$1.79M |
|
|
EPAY
2653
DELISTED
Bottomline Technologies Inc
EPAY
| $887K | ﹤0.01% |
15,704
-55,705
| -78% | -$3.15M |
|
2654
Medical Properties Trust
MPW
$3.08B
| $886K | ﹤0.01% |
37,501
-716,539
| -95% | -$16.9M |
|
|
KWAC
2655
DELISTED
Kingswood Acquisition Corp.
KWAC
| $885K | ﹤0.01% |
87,638
| – | – |
|
2656
Simpson Manufacturing
SSD
$7.86B
| $884K | ﹤0.01% |
6,353
-35,102
| -85% | -$4.88M |
|
2657
Vitamin Cottage Natural Grocers
NGVC
$859M
| $883K | ﹤0.01% |
61,997
+6,438
| +12% | +$91.7K |
|
2658
Newegg Commerce
NEGG
$901M
| $881K | ﹤0.01% |
+4,247
| New | +$881K |
|
2659
Moelis & Co
MC
$5.54B
| $878K | ﹤0.01% |
14,050
-75,925
| -84% | -$4.74M |
|
2660
Zura Bio
ZURA
$130M
| $874K | ﹤0.01% |
+88,597
| New | +$874K |
|
2661
GCM Grosvenor
GCMG
$685M
| $873K | ﹤0.01% |
83,166
+72,329
| +667% | +$759K |
|
2662
Janus Henderson
JHG
$7.01B
| $873K | ﹤0.01% |
20,824
-244,916
| -92% | -$10.3M |
|
2663
Novanta
NOVT
$4.12B
| $872K | ﹤0.01% |
4,945
-13
| -0.3% | -$2.29K |
|
2664
Option Care Health
OPCH
$4.62B
| $871K | ﹤0.01% |
30,642
-255,712
| -89% | -$7.27M |
|
|
ADOC
2665
DELISTED
Edoc Acquisition Corp. Class A Ordinary Share
ADOC
| $870K | ﹤0.01% |
84,956
| – | – |
|
2666
Fifth Third Bancorp
FITB
$30.2B
| $869K | ﹤0.01% |
+19,946
| New | +$869K |
|
2667
GXO Logistics
GXO
$5.84B
| $869K | ﹤0.01% |
9,572
+1,813
| +23% | +$165K |
|
2668
TD Synnex
SNX
$12.5B
| $866K | ﹤0.01% |
7,574
-6,912
| -48% | -$790K |
|
2669
M/I Homes
MHO
$4.07B
| $864K | ﹤0.01% |
13,893
-13,458
| -49% | -$837K |
|
2670
Passage Bio
PASG
$22.3M
| $863K | ﹤0.01% |
+6,795
| New | +$863K |
|
2671
REX American Resources
REX
$1.01B
| $863K | ﹤0.01% |
26,961
+6,996
| +35% | +$224K |
|
|
CZOO
2672
DELISTED
Cazoo Group Ltd
CZOO
| $861K | ﹤0.01% |
71
-179
| -72% | -$2.17M |
|
|
SWCH
2673
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $860K | ﹤0.01% |
30,043
-37,639
| -56% | -$1.08M |
|
2674
OneSpan
OSPN
$588M
| $858K | ﹤0.01% |
+50,701
| New | +$858K |
|
|
AXDX
2675
DELISTED
Accelerate Diagnostics
AXDX
| $856K | ﹤0.01% |
16,395
+2,001
| +14% | +$104K |
|